Cargando…

Proteomics for Early Detection of Non-Muscle-Invasive Bladder Cancer: Clinically Useful Urine Protein Biomarkers

Bladder cancer is the fourth most common cancer in men, and most cases are non-muscle-invasive. A high recurrence rate is a critical problem in non-muscle-invasive bladder cancer. The availability of few urine tests hinders the effective detection of superficial and small bladder tumors. Cystoscopy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ahn, Jae-Hak, Kang, Chan-Koo, Kim, Eun-Mee, Kim, Ah-Ram, Kim, Aram
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8950253/ https://www.ncbi.nlm.nih.gov/pubmed/35330146 http://dx.doi.org/10.3390/life12030395

Ejemplares similares

Cell-Free microRNA-214 From Urine as a Biomarker for Non-Muscle-Invasive Bladder Cancer
por: Kim, Sung Min, et al.
Publicado: (2013)

Urine Proteomics and Biomarkers in Renal Disease
por: Kim, Min Jeong, et al.
Publicado: (2011)

Discovery of urine biomarkers for lupus nephritis via quantitative and comparative proteome analysis
por: Kwon, Oh Chan, et al.
Publicado: (2021)

Next-Generation Proteomics–Based Discovery, Verification, and Validation of Urine Biomarkers for Bladder Cancer Diagnosis
por: Suh, Jungyo, et al.
Publicado: (2022)

Altered Proteome of Extracellular Vesicles Derived from Bladder Cancer Patients Urine
por: Lee, Jingyun, et al.
Publicado: (2018)

Tumor heterogeneity in muscle-invasive bladder cancer
por: Kang, Ho Won, et al.
Publicado: (2020)

Urine Endocannabinoids as Novel Non-Invasive Biomarkers for Bladder Cancer at Early Stage
por: Vago, Riccardo, et al.
Publicado: (2020)

Advancing Patient Care: Innovative Use of Near-Infrared Spectroscopy for Monitoring Urine Volume in Neurogenic Bladder
por: Kang, Byeong-Il, et al.
Publicado: (2023)

Epigenetic Markers for Bladder Cancer in Urine
por: Kim, Wun-Jae, et al.
Publicado: (2007)

Perioperative systemic therapy in muscle invasive bladder cancer: Current standard method, biomarkers and emerging strategies
por: Kim, Kyung Hwan, et al.
Publicado: (2023)

Potential urine proteomics biomarkers for primary nephrotic syndrome
por: Choi, Young Wook, et al.
Publicado: (2017)

Recommended oral sodium bicarbonate administration for urine alkalinization did not affect the concentration of mitomycin-C in non-muscle invasive bladder cancer patients
por: Seo, Ho Kyung, et al.
Publicado: (2017)

Clinical evaluation of urine laminin‐γ2 monomer as a potent biomarker for non‐muscle invasive bladder cancer
por: Karashima, Takashi, et al.
Publicado: (2022)

Single Institutional Experience of Bladder-Preserving Trimodality Treatment for Muscle-Invasive Bladder Cancer
por: Joung, Jae Young, et al.
Publicado: (2008)

Somatic Mutation of the Non-Muscle-Invasive Bladder Cancer Associated with Early Recurrence
por: Yu, Seong Hyeon, et al.
Publicado: (2023)

Metabolomics of Non-muscle Invasive Bladder Cancer: Biomarkers for Early Detection of Bladder Cancer
por: Cheng, Xiangming, et al.
Publicado: (2018)

Proteomics research on muscle-invasive bladder transitional cell carcinoma
por: Niu, Hai Tao, et al.
Publicado: (2011)

Metabolic Profiling of Eccentric Exercise-Induced Muscle Damage in Human Urine
por: Jang, Hyun-Jun, et al.
Publicado: (2018)

Prognostic Significance of CREB-Binding Protein and CD81 Expression in Primary High Grade Non-Muscle Invasive Bladder Cancer: Identification of Novel Biomarkers for Bladder Cancer Using Antibody Microarray
por: Lee, Myung-Shin, et al.
Publicado: (2015)

Overexpression of caldesmon is associated with tumor progression in patients with primary non-muscle-invasive bladder cancer
por: Lee, Myung-Shin, et al.
Publicado: (2015)

Identification and validation of methylated PENK gene for early detection of bladder cancer using urine DNA
por: Oh, Tae Jeong, et al.
Publicado: (2022)

A mitochondrial proteome profile indicative of type 2 diabetes mellitus in skeletal muscles
por: Chae, Sehyun, et al.
Publicado: (2018)

Stromal proteome expression profile and muscle-invasive bladder cancer research
por: Niu, Haitao, et al.
Publicado: (2012)

Perioperative immunotherapy for muscle-invasive bladder cancer
por: Kim, In-Ho, et al.
Publicado: (2020)

Detection of Bladder Cancer Using Proteomic Profiling of Urine Sediments
por: Majewski, Tadeusz, et al.
Publicado: (2012)

Identification of S100A8-correlated genes for prediction of disease progression in non-muscle invasive bladder cancer
por: Kim, Seon-Kyu, et al.
Publicado: (2010)

Predictive value of progression-related gene classifier in primary non-muscle invasive bladder cancer
por: Kim, Wun-Jae, et al.
Publicado: (2010)

Urine Micro-RNA Signature as a Potential Non-Invasive Diagnostic Biomarker in Bladder Cancer
por: Mamdouh, Samah, et al.
Publicado: (2023)

Role of PET/CT in muscle-invasive bladder cancer
por: Kim, Seok-ki
Publicado: (2020)

Non-muscle invasive bladder cancer biomarkers beyond morphology
por: De Carlo, Camilla, et al.
Publicado: (2022)

Comparing CxBladder to Urine Cytology as Adjunct to Cystoscopy in Surveillance of Non-muscle Invasive Bladder Cancer—A Pilot Study
por: Chai, C. A., et al.
Publicado: (2021)

Diagnostic accuracy, clinical utility and influence on decision‐making of a methylation urine biomarker test in the surveillance of non‐muscle‐invasive bladder cancer
por: D'Andrea, David, et al.
Publicado: (2019)

Neoadjuvant chemotherapy with gemcitabine and cisplatin followed by selective bladder preservation chemoradiotherapy in muscle-invasive urothelial carcinoma of bladder
por: Sung, Hyun Hwan, et al.
Publicado: (2022)

00005 Urine tumor DNA detects minimal residual disease in muscle-invasive bladder cancer treated with curative-intent radical cystectomy
por: Chen, Kevin, et al.
Publicado: (2021)

Detection of functional antigen-specific T cells from urine of non-muscle invasive bladder cancer patients
por: Pieraerts, Claire, et al.
Publicado: (2012)

Rapid Detection of Recurrent Non-Muscle Invasive Bladder Cancer in Urine Using ATR-FTIR Technology
por: El-Falouji, Abdullah I., et al.
Publicado: (2022)

Decreased DBC1 Expression Is Associated With Poor Prognosis in Patients With Non-Muscle-Invasive Bladder Cancer
por: Shim, Ui Jae, et al.
Publicado: (2013)

Review of non-invasive urinary biomarkers in bladder cancer
por: Lee, Hyung-Ho, et al.
Publicado: (2020)

The Direct Anti-Cancer Effect of a Single Instillation of Epirubicin after Transurethral Resection of Bladder Tumor for Non-Muscle-Invasive Bladder Cancer
por: Shin, Yu Seob, et al.
Publicado: (2012)

Accurate Detection of Urothelial Bladder Cancer Using Targeted Deep Sequencing of Urine DNA
por: Lee, Dongin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_td1qj3mfir7honlfd86domd8s2